FDA Drug Application (088021) for BONTRIL by VALEANT

Back to FDA Applications sponsored by VALEANT

Application Number088021
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage105MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBONTRIL
Active IngredientPHENDIMETRAZINE TARTRATE

Active IngredientCount
List of drugs with Active Ingredient PHENDIMETRAZINE TARTRATE19


Back to FDA Applications sponsored by VALEANT